0001415889-24-015475.txt : 20240604 0001415889-24-015475.hdr.sgml : 20240604 20240604184845 ACCESSION NUMBER: 0001415889-24-015475 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240603 FILED AS OF DATE: 20240604 DATE AS OF CHANGE: 20240604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kunkel Lori Anne CENTRAL INDEX KEY: 0001536368 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39269 FILM NUMBER: 241020078 MAIL ADDRESS: STREET 1: C/O PHARMACYCLICS, INC. STREET 2: 995 EAST ARQUES AVENUE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oric Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001796280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 471787157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 240 E. GRAND AVE. STREET 2: 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 388-5600 MAIL ADDRESS: STREET 1: 240 E. GRAND AVE. STREET 2: 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form4-06042024_100642.xml X0508 4 2024-06-03 0001796280 Oric Pharmaceuticals, Inc. ORIC 0001536368 Kunkel Lori Anne C/O ORIC PHARMACEUTICALS, INC. 240 EAST GRAND AVE., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 true false false false 0 Common Stock 2024-06-03 4 M 0 20500 3.75 A 20500 D Stock Option (right to buy) 3.75 2024-06-03 4 M 0 20500 0 D 2032-06-16 Common Stock 20500 33200 D (A) 20,500 of the shares subject to the option shall vest on the earlier of (i) June 17, 2023 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant, and (B) one thirty-sixth (1/36th) of the remaining 33,200 shares subject to the option shall vest on each monthly anniversary of June 17, 2022. /s/ Christian Kuhlen, attorney-in-fact 2024-06-04